KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Short term Debt: 2015-2025

Historic Short term Debt for BeOne Medicines (ONC) over the last 9 years, with Sep 2025 value amounting to $813.3 million.

  • BeOne Medicines' Short term Debt fell 5.85% to $813.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.3 million, marking a year-over-year decrease of 5.85%. This contributed to the annual value of $851.5 million for FY2024, which is 23.70% up from last year.
  • Latest data reveals that BeOne Medicines reported Short term Debt of $813.3 million as of Q3 2025, which was up 0.61% from $808.4 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Short term Debt ranged from a high of $863.8 million in Q3 2024 and a low of $281.8 million during Q1 2023.
  • Moreover, its 3-year median value for Short term Debt was $808.4 million (2025), whereas its average is $681.7 million.
  • Its Short term Debt has fluctuated over the past 5 years, first soared by 3,485.10% in 2021, then slumped by 30.83% in 2023.
  • Over the past 5 years, BeOne Medicines' Short term Debt (Quarterly) stood at $427.6 million in 2021, then slumped by 30.33% to $297.9 million in 2022, then spiked by 131.10% to $688.4 million in 2023, then grew by 23.70% to $851.5 million in 2024, then declined by 5.85% to $813.3 million in 2025.
  • Its Short term Debt was $813.3 million in Q3 2025, compared to $808.4 million in Q2 2025 and $763.5 million in Q1 2025.